Ueland, T., Kleveland, O., Michelsen, A. E., Wiseth, R., Damås, J. K., Aukrust, P., . . . Yndestad, A. (2018). Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction. Open Heart.
Citação norma ChicagoUeland, Thor, Ola Kleveland, Annika E. Michelsen, Rune Wiseth, Jan Kristian Damås, Pål Aukrust, Lars Gullestad, Bente Halvorsen, and Arne Yndestad. "Serum PCSK9 Is Modified By Interleukin-6 Receptor Antagonism in Patients With Hypercholesterolaemia Following Non-ST-elevation Myocardial Infarction." Open Heart 2018.
Citação norma MLAUeland, Thor, et al. "Serum PCSK9 Is Modified By Interleukin-6 Receptor Antagonism in Patients With Hypercholesterolaemia Following Non-ST-elevation Myocardial Infarction." Open Heart 2018.